CDC urges wider use of meningococcal vaccine

The Centers for Disease Control and Prevention has issued new recommendations that all 11- and 12-year-old children should be immunized against meningococcal bacteria, which can cause often fatal infections. The agency urged wider use of Sanofi Pasteur's Menactra, which has been recommended for adolescents and freshmen in college. In particular, the CDC wants all college freshmen living in dorms inoculated. Meningococcal disease afflicts about 3,000 people a year and kills about one-in-10.

- read this story from The New York Times for more on the recommendation

Suggested Articles

The public financing will enable Monopar to start a phase 3 trial of a prophylactic treatment for a side effect of chemoradiotherapy. 

The dispute centers on whether Asa Abeliovich used Alector’s confidential information in connection with his work for Prevail Therapeutics.

GSK poaches Merck KGaA's Martinez-Davis to helm pharma stateside; Bulto named Novartis U.S. pharma head; Allergan's Saunders set for huge parachute.